|
|
|
Volumn 10, Issue 1, 2000, Pages 63-69
|
|
What to do when standard therapy fails?
|
|
Author keywords
Chronic hepatitis C; Interferon; Non responders; Ribavirin
|
|
Indexed keywords
AMANTADINE;
ANTIVIRUS AGENT;
CORTICOSTEROID;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERFERON;
KETOPROFEN;
LEVAMISOLE;
NONSTEROID ANTIINFLAMMATORY AGENT;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RECOMBINANT INTERFERON;
RIBAVIRIN;
RIMANTADINE;
RITONAVIR;
THYMOSIN ALPHA1;
VIRUS RNA;
ZIDOVUDINE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG RESPONSE;
GENOTYPE;
HEPATITIS C;
HUMAN;
LIFE EXPECTANCY;
LIVER CIRRHOSIS;
RETREATMENT;
REVIEW;
TREATMENT FAILURE;
VIRUS LOAD;
AMANTADINE;
ANTIVIRAL AGENTS;
DRUG COMBINATIONS;
GENOTYPE;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERONS;
LIFE EXPECTANCY;
LIVER CIRRHOSIS;
REMISSION INDUCTION;
RETREATMENT;
RIBAVIRIN;
RISK FACTORS;
RNA, VIRAL;
TIME FACTORS;
TREATMENT FAILURE;
VIRAL LOAD;
|
|
EID: 0034018032
PISSN: 11218142
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (36)
|
